Company Profile
PROCEPT BioRobotics Stock Price, News & Catalysts
- Ticker:
- PRCT
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
21.09 USD (-2.59%)
Close
Last updated: August 17, 2026
1.52B USD
Market cap
Why the stock is moving
Following the latest company update, “PROCEPT BioRobotics® to Attend the Baird 2026 Global Healthcare Conference on September 15, 2026”, PRCT closed down 2.59% at $21.09 on Aug 17, 2026. The move occurred in the trading session associated with this conference / presentation update.
Company overview
Urology Robotics
PROCEPT BioRobotics develops robotic systems for the surgical treatment of benign prostatic hyperplasia. Its technology is designed to standardize tissue removal while preserving outcomes across different prostate sizes and anatomies.
Aquablation Therapy
Aquablation uses a robotically controlled, heat-free waterjet to remove obstructive prostate tissue. The procedure is planned from imaging and is intended to reduce dependence on surgeon technique compared with manually executed resection.
HYDROS Platform
The HYDROS Robotic System is the company’s current AI-enabled platform for Aquablation. Its FirstAssist AI software supports personalized image-guided planning, while recurring handpiece sales create a procedure-linked revenue stream alongside capital-system placements.
Future catalysts
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of PROCEPT BioRobotics (PRCT)?
PROCEPT BioRobotics (PRCT) most recently closed at 21.09 USD, a -2.59% move versus the previous session.
What is the market cap of PROCEPT BioRobotics (PRCT)?
PROCEPT BioRobotics currently has a market capitalization of 1.52B USD on BioPharmSignal.
What does PROCEPT BioRobotics do?
Urology Robotics PROCEPT BioRobotics develops robotic systems for the surgical treatment of benign prostatic hyperplasia. Its technology is designed to standardize tissue removal while preserving outcomes across different prostate sizes and anatomies. Aquablation Therapy Aquablation uses a robotically controlled, heat-free waterjet to remove obstructive...
On which exchange is PRCT stock listed?
PROCEPT BioRobotics (PRCT) is associated with NASDAQ, United States, Biopharma.
What is Urology?
Urology Robotics PROCEPT BioRobotics develops robotic systems for the surgical treatment of benign prostatic hyperplasia.
Which conditions is PROCEPT BioRobotics targeting with Urology?
Urology Robotics PROCEPT BioRobotics develops robotic systems for the surgical treatment of benign prostatic hyperplasia. Its technology is designed to standardize tissue removal while preserving outcomes across different prostate sizes and anatomies. Aquablation Therapy Aquablation uses a robotically controlled, heat-free waterjet to remove obstructive...
What is Robotics?
Urology Robotics PROCEPT BioRobotics develops robotic systems for the surgical treatment of benign prostatic hyperplasia.
What is BioRobotics?
Urology Robotics PROCEPT BioRobotics develops robotic systems for the surgical treatment of benign prostatic hyperplasia.